Yes you could be correct but it says "up to 6 months"
Also, I wouldn't be surprised of updates on the way:
The study is designed as a dose escalation study. Dosing will commence with the lowest dose cohort (0.03 mg/kg ARG007/placebo). Once at least 6 subjects in a given dose cohort completed dosing, safety data will be reviewed by a SRC prior to dose escalation to the next dose cohort. The study will consist of a screening period, treatment period and follow-up period.
Yes you could be correct but it says "up to 6 months"Also, I...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
77.0¢ |
Change
-0.055(6.67%) |
Mkt cap ! $95.24M | |||
| Open | High | Low | Value | Volume |
| 83.0¢ | 83.0¢ | 75.0¢ | $223.5K | 283.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 23353 | 77.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 78.5¢ | 1100 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| AGN (ASX) Chart |